GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Peijia Medical Ltd (HKSE:09996) » Definitions » Cash Ratio

Peijia Medical (HKSE:09996) Cash Ratio : 6.74 (As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Peijia Medical Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Peijia Medical's Cash Ratio for the quarter that ended in Jun. 2023 was 6.74.

Peijia Medical has a Cash Ratio of 6.74. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Peijia Medical's Cash Ratio or its related term are showing as below:

HKSE:09996' s Cash Ratio Range Over the Past 10 Years
Min: 2.13   Med: 11.07   Max: 71.14
Current: 6.11

During the past 6 years, Peijia Medical's highest Cash Ratio was 71.14. The lowest was 2.13. And the median was 11.07.

HKSE:09996's Cash Ratio is ranked better than
86.59% of 835 companies
in the Medical Devices & Instruments industry
Industry Median: 1.23 vs HKSE:09996: 6.11

Peijia Medical Cash Ratio Historical Data

The historical data trend for Peijia Medical's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peijia Medical Cash Ratio Chart

Peijia Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
Get a 7-Day Free Trial 10.35 55.45 19.34 3.01 6.11

Peijia Medical Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 19.34 11.07 3.01 6.74 6.11

Competitive Comparison of Peijia Medical's Cash Ratio

For the Medical Devices subindustry, Peijia Medical's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Peijia Medical's Cash Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Peijia Medical's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Peijia Medical's Cash Ratio falls into.



Peijia Medical Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Peijia Medical's Cash Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash Ratio (A: Dec. 2022 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=1944.456/645.487
=3.01

Peijia Medical's Cash Ratio for the quarter that ended in Jun. 2023 is calculated as:

Cash Ratio (Q: Jun. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=1169.286/173.477
=6.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Peijia Medical  (HKSE:09996) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Peijia Medical Cash Ratio Related Terms

Thank you for viewing the detailed overview of Peijia Medical's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Peijia Medical (HKSE:09996) Business Description

Traded in Other Exchanges
N/A
Address
8 Zhongtian Street, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN
Peijia Medical Ltd is focused on the interventional procedural, transcatheter valve therapeutic, and the neurointerventional procedural medical device market in China. The company's product candidates include Transcatheter Aortic Valve Replacement products, Transcatheter Mitral Valve Replacement/Transcatheter Tricuspid Valve Replacement products, Ancillary products, Neurointerventional products, and its product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates. Its operating segments are Transcatheter Valve Therapeutic Business and Neurointerventional Business.
Executives
Jinnius Drive Trust 2103 Interests held jointly with another person
Xinyue International Limited 2103 Interests held jointly with another person
Ye Hong 2103 Interests held jointly with another person
Zhang Ping Ye 2103 Interests held jointly with another person
Zhang Yi 2301 Trustee
Hanlindale Trust 2103 Interests held jointly with another person
Hillhouse Investment Management, Ltd. 2102 Investment manager
Hh Imv Holdings, L.p. 2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p. 2201 Interest of corporation controlled by you
Hh Sum-xxiv Holdings Limited 2101 Beneficial owner
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Lav Asset Management (hong Kong) Limited 2102 Investment manager
Shi Yi 2201 Interest of corporation controlled by you

Peijia Medical (HKSE:09996) Headlines

No Headlines